Tanzania's medicines regulator, which authorises medicines, devices and clinical trials. As the Tanzania Food and Drugs Authority it was confirmed by WHO in 2018 as the first African regulator to reach maturity level 3, and it kept that level after a 2023 reassessment.
TMDA regulates medicines, medical devices and diagnostics for the mainland; Zanzibar has its own Zanzibar Food and Drug Agency. It has offices in Dodoma and Dar es Salaam; the coordinates are an approximate Dodoma city point. Its predecessor, the Tanzania Food and Drugs Authority, was established in July 2003.
In December 2018 WHO Africa announced that Tanzania was the first confirmed country in Africa with a well-functioning regulatory system for medical products: after self-assessments and a formal WHO evaluation of the Tanzania Food and Drugs Authority and the Zanzibar Food and Drug Agency, the mainland authority met all indicators for maturity level 3 on WHO's Global Benchmarking Tool. In a public notice dated 17 October 2025, TMDA said it had kept maturity level 3 after WHO's 2023 re-benchmarking and that its long-term goal is level 4.
NIAID's ClinRegs profile, summarising TMDA's clinical trial guidelines, says TMDA completes evaluation of a trial application within 60 working days, or within 30 working days on a fast track for which the applicant pays twice the fee, and that the clock stops while TMDA waits for answers to its queries. Ethics clearance comes from the National Health Research Ethics Committee at the National Institute for Medical Research.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/